Search Results - Allison Avrich Ciesla

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Adolescent Outcomes of Children With Early Speech Sound Disorders With and Without Language Impairment

    Adolescent Outcomes of Children With Early Speech Sound Disorders With and Without Language Impairment by Barbara Lewis, Lisa Freebairn, Jessica Tag, Allison Avrich Ciesla, Sudha K. Iyengar, Catherine M. Stein, H. Gerry Taylor

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Maternal prenatal infection and anxiety predict neurodevelopmental outcomes in middle childhood.

    Maternal prenatal infection and anxiety predict neurodevelopmental outcomes in middle childhood. by Thomas G. O’Connor, Allison Avrich Ciesla, Ana Vallejo Sefair, Loralei L. Thornburg, Alan S. Brown, Vivette Glover, Kieran J. O’Donnell

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024

    Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Am... by Ruth Link‐Gelles, Allison Avrich Ciesla, Josephine Mak, Joseph D. Miller, Benjamin J. Silk, Anastasia S. Lambrou, Clinton R. Paden, Philip Shirk, Amadea Britton, Zachary Smith, Katherine E. Fleming-Dutra

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022

    Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 by Ruth Link‐Gelles, Allison Avrich Ciesla, Katherine E. Fleming-Dutra, Zachary Smith, Amadea Britton, Ryan E. Wiegand, Joseph D. Miller, Emma K. Accorsi, Stephanie J. Schrag, Jennifer R. Verani, Nong Shang, Gordana Derado, Tamara Pilishvili

    Published 2022
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Testing Program, United States, July 2022–February 2023

    Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3–5 Years — Increasing Community Access to Tes... by Katherine E. Fleming-Dutra, Allison Avrich Ciesla, Lauren E. Roper, Zachary Smith, Joseph D. Miller, Emma K. Accorsi, Jennifer R. Verani, Nong Shang, Gordana Derado, Ryan E. Wiegand, Tamara Pilishvili, Amadea Britton, Ruth Link‐Gelles

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Cohort profile: Understanding Pregnancy Signals and Infant Development (UPSIDE): a pregnancy cohort study on prenatal exposure mechanisms for child health

    Cohort profile: Understanding Pregnancy Signals and Infant Development (UPSIDE): a pregnancy cohort study on prenatal exposure mechanisms for child health by Thomas G. O’Connor, Meghan Best, Jessica Brunner, Allison Avrich Ciesla, Allison Cunning, Ntemena Kapula, Amber Kautz, Leena Khoury, Allison Macomber, Ying Meng, Richard K. Miller, Hannah R. Murphy, Carolyn M. Salafia, Ana Vallejo Sefair, Jishyra Serrano, Emily S. Barrett

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023

    Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages... by Ruth Link‐Gelles, Allison Avrich Ciesla, Lauren E. Roper, Heather M. Scobie, Akilah R. Ali, Joseph D. Miller, Ryan E. Wiegand, Emma K. Accorsi, Jennifer R. Verani, Nong Shang, Gordana Derado, Amadea Britton, Zachary Smith, Katherine E. Fleming-Dutra

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISION Network, United States, July 2022–June 2023

    Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months–5 Years — VISI... by Ruth Link‐Gelles, Allison Avrich Ciesla, Elizabeth Rowley, Nicola P. Klein, Allison L. Naleway, Amanda B. Payne, Anupam B. Kharbanda, Karthik Natarajan, Malini B. DeSilva, Kristin Dascomb, Stephanie A. Irving, Ousseny Zerbo, Sarah E. Reese, Ryan E. Wiegand, Morgan Najdowski, Toan C. Ong, Suchitra Rao, Melissa S. Stockwell, Ashley Stephens, Kristin Goddard, Yessica C. Martinez, Zachary A. Weber, Bruce Fireman, John Hansen, Julius Timbol, Shaun J. Grannis, Michelle A. Barron, Peter J. Embí, Sarah W. Ball, Manjusha Gaglani, Nancy Grisel, Julie Arndorfer, Mark W. Tenforde, Katherine E. Fleming-Dutra

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: